EUVIMEDEUVIMED entdecken
Crossref

Boosting Type-I and Type-II ROS Production of Water-Soluble Porphyrin for Efficient Hypoxic Tumor Therapy

Han Sun, Ruihua Guo, Yanhui Guo, Jitao Song iD, Zhiliang Li iD, Fengling Song iD

Molecular Pharmaceutics · 02.01.2023 · 20 (1) · 606-615

DOI: 10.1021/acs.molpharmaceut.2c00822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 18.11.2022. Verfasst von Han Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Science and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, Shandong266237, Ch…. Hauptthemen laut MEDLINE: Photochemotherapy, Porphyrins, Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shandong University, Key Research and Development Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPorphyrinsNeoplasmsHumansPhotosensitizing AgentsReactive Oxygen SpeciesWaterHypoxiaCell Line, Tumor

Stichwörter der Autor:innen

cationic porphyrinhypoxiaphotodynamic therapyphotosensitizerstumors

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesPorphyrinsWater

Autor:innen und Institutionen

  • Institute of Molecular Science and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, Shandong266237, China.

ORCID-Profile: Jitao Song, Zhiliang Li, Fengling Song

Förderung

  • Shandong University
  • Key Research and Development Program of Shandong Province

Zitieren

APA

Sun, H., Guo, R., Guo, Y., Song, J., Li, Z., & Song, F. (2023). Boosting Type-I and Type-II ROS Production of Water-Soluble Porphyrin for Efficient Hypoxic Tumor Therapy. Molecular Pharmaceutics, 20(1), 606-615. https://doi.org/10.1021/acs.molpharmaceut.2c00822

Vancouver

Sun H, Guo R, Guo Y, Song J, Li Z, Song F. Boosting Type-I and Type-II ROS Production of Water-Soluble Porphyrin for Efficient Hypoxic Tumor Therapy. Molecular Pharmaceutics. 2023;20(1):606-615. doi:10.1021/acs.molpharmaceut.2c00822

BibTeX
@article{Sun2023,
  author = {Sun, Han and Guo, Ruihua and Guo, Yanhui and Song, Jitao and Li, Zhiliang and Song, Fengling},
  title = {Boosting Type-I and Type-II ROS Production of Water-Soluble Porphyrin for Efficient Hypoxic Tumor Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {1},
  pages = {606--615},
  doi = {10.1021/acs.molpharmaceut.2c00822}
}
Kostenlos starten →